ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 18.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $111,000 | -72.0% | 76,866 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $396,000 | +26.1% | 76,866 | +42.8% | 0.00% | 0.0% |
| Q3 2021 | $314,000 | -33.0% | 53,818 | -7.5% | 0.00% | -33.3% |
| Q2 2021 | $469,000 | +29.9% | 58,170 | +34.1% | 0.00% | +50.0% |
| Q1 2021 | $361,000 | +69.5% | 43,363 | +54.2% | 0.00% | 0.0% |
| Q4 2020 | $213,000 | -28.5% | 28,124 | +0.6% | 0.00% | -33.3% |
| Q3 2020 | $298,000 | -46.0% | 27,963 | -23.2% | 0.00% | -50.0% |
| Q2 2020 | $552,000 | +265.6% | 36,417 | +100.7% | 0.01% | +200.0% |
| Q1 2020 | $151,000 | -40.1% | 18,143 | +22.6% | 0.00% | -33.3% |
| Q4 2019 | $252,000 | +9.1% | 14,793 | +18.8% | 0.00% | -25.0% |
| Q3 2019 | $231,000 | -12.5% | 12,449 | +7.7% | 0.00% | -20.0% |
| Q2 2019 | $264,000 | -12.9% | 11,554 | -19.7% | 0.01% | -16.7% |
| Q1 2019 | $303,000 | +90.6% | 14,392 | +6.2% | 0.01% | +50.0% |
| Q4 2018 | $159,000 | -7.0% | 13,556 | +82.2% | 0.00% | 0.0% |
| Q3 2018 | $171,000 | – | 7,442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,213,326 | $18,386,000 | 10.92% |
| ORACLE INVESTMENT MANAGEMENT INC | 3,776,121 | $31,417,000 | 4.70% |
| GRIFFIN ASSET MANAGEMENT, INC. | 1,358,644 | $11,304,000 | 1.44% |
| Selkirk Management LLC | 288,805 | $2,403,000 | 0.72% |
| Chicago Capital, LLC | 1,593,126 | $13,255,000 | 0.56% |
| Cannell & Co. | 1,097,419 | $9,131,000 | 0.29% |
| TCI Wealth Advisors, Inc. | 55,586 | $462,000 | 0.20% |
| Belpointe Asset Management LLC | 197,853 | $1,646,000 | 0.14% |
| ALGERT GLOBAL LLC | 29,580 | $246,000 | 0.08% |
| THOMPSON INVESTMENT MANAGEMENT, INC. | 60,900 | $507,000 | 0.08% |